Delhi HC Rejects Sun Pharma Lab Plea In ‘Letroz’ Trademark Case

MUMBAI : The Delhi High Court has rejected a plea by Sun Pharmaceutical Laboratories Ltd wherein it claimed that Hetero Healthcare Ltd has infringed on its trademark ‘Letroz’, a generic drug for second line treatment of advanced breast cancer.

A bench led by Justice Amit Mahajan said “Sun, in the present case, cannot be allowed to monopolize the INN ‘Letrozole’. The mark, ‘Letroz’, is not similar to the trademark ‘Letero’ merely because both the parties have adopted the initial letters (Sun adopted the first six and Hetero adopted the first three) of the INN ‘Letrozole’”.

Essentially, International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property.

Earlier, Sun had filed a suit before a commercial court, alleging infringement of its ‘Letroz’ trademark and passing off and seeking a decree of permanent injunction restraining Hetero from using the trademark ‘Letero’ for the drug.

The commercial court, however, rejected it in April this year.

In its petition, Sun claimed to be one of the world’s top generic pharma companies. It said that it secured registration of the trademark ‘Letroz’ in October 2010 under Class 5.

Sun further claimed that due to the trademark registration, it has a statutory right to exclusively use ‘Letroz’ and is entitled to restrain Hetero from using its trademark.

According to Sun, the product’s outstanding quality and high performance are what caused a surge in sales of ₹8.34 crores in the 2016–17 fiscal year. Additionally, it stated that it spent a significant amount of money promoting Letroz.

Reference: Sun Pharmaceutical Laboratories Ltd vs Hetero Healthcare Ltd & Anr., Delhi High Court, FAO (COMM) 96/2022, CM Appl. 29651-29653/2022, D/j 26.8.2022 

  • Related Posts

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    World’s 1st Dual Console Complex Robotic Beating Heart TECAB performed in India’   New Delhi: SSiMantra, the only ‘Made in India’ best in class surgical robot is as usual always…

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Three teams inspected several wholesale medicine shops following complaints of sales without bills, storage irregularities and alleged illegal trading of government-supplied medicines. Patna: The Drug Department has launched an inspection…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested